A short time after Mallika Lala, PhD, finished her presentation titled “Pembrolizumab 400 mg Q6W dosing: First clinical outcomes...
Early detection of most cancers is an elusive and daunting task; nevertheless, it has remained a top priority for...
As the COVID-19 pandemic swept the globe this spring, the American Association for Cancer Research (AACR) launched a major...
Testicular cancer forms when cancerous cells develop in one or both testicles. Almost all cases of the disease begin...
Today is International Day of Women and Girls in Science, a United Nations initiative aimed at encouraging full and...
The U.S. Food and Drug Administration (FDA) approved a new molecularly targeted therapeutic called fam-trastuzumab deruxtecan-nxki (Enhertu) for treating...
The new year began with the good news that death rates from cancer are continuing their steady decline. A...
In the final days of 2019, the U.S. Food and Drug Administration (FDA) expanded the use of a previously...
In November and the first half of December, the U.S. Food and Drug Administration (FDA) announced three approvals for...
Editor’s note: When the San Antonio Breast Cancer Symposium (SABCS) kicks off next week, researchers will present the results...